Dipeptidyl Peptidase 4 Inhibitor [phsu]
vildagliptin [orch, phsu]
Plasminogen [aapp, bacs, phsu]
activator 1 [gngm]
Inhibitor [qlco]
Patients [podg]
Diabetes Mellitus [dsyn]
Dipeptidyl-Peptidase 4 Inhibitors [phsu]
Affect [menp]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Triglyceride Metabolism [moft]
Prognostic Factor [clna]
Cardiovascular disease [dsyn]
diabetic [fndg]
Patients [podg]
Conduct [inbe]
prospective [resa]
randomized [resa]
Study [mnob]
Assigned [ftcn]
Type 2 [clas]
diabetic [fndg]
Patients [podg]
Controlled [ftcn]
antidiabetic [phsu]
therapy [ftcn]
vildagliptin [orch, phsu]
Group [idcn]
mg% [qnco]
N NOS [aapp, imft]
Control Group [grup]
N NOS [aapp, imft]
Primary [qlco]
Efficacy [qlco]
Parameter [spco]
secondary [neop]
End Point [qlco]
triglyceride lipoprotein [aapp, lipd]
Rich [qlco]
vildagliptin [orch, phsu]
Group [idcn]
Decrease [qlco]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
P NOS [aapp, imft]
decreases [qnco]
serum triglyceride [lbpr]
remnant-like particle cholesterol [aapp, lipd]
Apolipoprotein B [aapp, bacs]
P NOS [aapp, imft]
P NOS [aapp, imft]
P NOS [aapp, imft]
Observed [ftcn]
Observed [ftcn]
Control Group [grup]
Multivariate Analyses [qnco]
Regression [patf]
Identified [qlco]
Absolute Change [idcn]
baseline [bodm]
Delta [inpr]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Fasting blood glucose [lbpr]
Haemoglobin A1c [aapp, bacs]
Independent [idcn]
Delta [inpr]
Triglyceride [bacs, lipd]
Delta [inpr]
remnant-like particle cholesterol [aapp, lipd]
Delta [inpr]
Apolipoprotein B [aapp, bacs]
treatment [ftcn]
Type 2 Diabetes [dsyn]
vildagliptin [orch, phsu]
PREVENT [phsu]
progression [patf]
Atherosclerotic Cardiovascular Disease [dsyn]
diabetic [fndg]
Patients [podg]
Decreasing [qlco]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Improving [qlco]
Triglyceride Metabolism [moft]
Reserve [acty]
